Navigation Links
Brin Wojcicki Foundation Announces $50-Million Challenge Grant to Michael J. Fox Foundation to Spur Progress Toward Parkinson's Cure
Date:5/31/2011

NEW YORK, May 31, 2011 /PRNewswire-USNewswire/ --Sergey Brin and Anne Wojcicki announced a $50-million challenge spurring existing and new donors at every level to give, or increase giving, to The Michael J. Fox Foundation for Parkinson's Research (MJFF). The Challenge is now in effect and will match all new or increased gifts to The Michael J. Fox Foundation on a one-to-one basis through year-end 2012.

The Brin Wojcicki Challenge will bolster MJFF's ongoing efforts to reshape drug development for Parkinson's disease. Founded in 2000, the Foundation has assembled a team with the expertise to continually identify the science closest and/or most critical to therapeutic breakthroughs, then designate or create the appropriate resources to push those research areas forward toward practical relevance for people living with the disease.

If the challenge is met, Ms. Wojcicki and Mr. Brin's personal giving to MJFF since 2004 will surpass $130 million. In addition to generally supporting the Foundation's research program expansion, their support has enabled MJFF to orchestrate and lead an integrated global effort to drive therapeutic development focused on the LRRK2 gene, the single greatest genetic contributor to Parkinson's disease discovered to date.

Mr. Brin carries the LRRK2 G2019S mutation that has been linked to a significant increase in risk for Parkinson's disease.  His mother, who was diagnosed with Parkinson's disease in 1999 and sits on the Foundation's Patient Council, also is a carrier of the mutation. MJFF funding programs enabled by Brin Wojcicki giving to date have resulted in the demonstration that LRRK2's kinase, or enzymatic, activity is required for the toxicity associated with Parkinson's disease (a finding with important implications for drug development) and the discovery of a powerful tool for detecting molecular changes in the LRRK2 gene associated with Parkinson's onset and progression.

"Anne and Sergey's generosity already has resulted in seminal contributions to the LRRK2 field by MJFF-funded researchers and an unprecedented level of collaboration among all players," said Todd Sherer, PhD, CEO of The Michael J. Fox Foundation. "We are excited to take on this Challenge — which we hope will inspire others to give generously — so that we can deploy similar strategies in other high-priority areas of PD research."

Michael J. Fox said: "Anne and Sergey's generosity to our Foundation, through their personal contributions and this Challenge, defies description. On behalf of the millions Parkinson's patients and their loved ones who stand to benefit, I'm more grateful than words can say."

Mr. Brin is co-founder of Google. Ms. Wojcicki is co-founder of 23andMe, a personal genetics company.

About The Michael J. Fox Foundation for Parkinson's Research

As the world's largest private funder of Parkinson's research, The Michael J. Fox Foundation is dedicated to accelerating a cure for Parkinson's disease and improved therapies for those living with the condition today. The Foundation pursues its goals through an aggressively funded, highly targeted research program coupled with active global engagement of scientists, Parkinson's patients, business leaders, clinical trial participants, donors and volunteers.  In addition to funding nearly $240 million in research to date, the Foundation has fundamentally altered the trajectory of progress toward a cure. Operating at the hub of worldwide Parkinson's research, the Foundation forges groundbreaking collaborations with industry leaders, academic scientists and government research funders; increases Parkinson's awareness through high-profile advocacy, events and outreach; and coordinates the grassroots involvement of thousands of Team Fox members around the world. For more information, visit: www.michaeljfox.org.


'/>"/>
SOURCE The Michael J. Fox Foundation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. SyntheZyme Wins Second National Science Foundation Grant to Commercialize Promising Biopesticide
2. Boston Scientific Supports Asthma Awareness Month With Donation to Asthma Foundation
3. Bill & Melinda Gates Foundation Funds Bold Ideas Including Empty Virus Shells to Improve Polio Immunity, Dirt-Charged Cell Phones, and Fertilizer Pellets that Reduce Health Risks
4. Kanzius Cancer Research Foundation Earns $1 for Each New Facebook Fan
5. Fueling Interventional Radiology Growth: SIR Foundation Announces Navilyst Medical Pledge
6. Newborn Possibilities Fund Awards Grant to Georgia Health Sciences University Foundation to Support Groundbreaking Pediatric Research
7. Yuma Therapeutics Awarded a Research Grant by the Alzheimers Drug Discovery Foundation to Develop Novel Therapeutics for Alzheimers Disease
8. FXB Center Partners With The Merck Company Foundation to Reduce Mother-to-Child HIV Transmission Rates in Botswana
9. Medco Foundation Donates $100,000 to Red Cross for Japanese Earthquake and Pacific Tsunami Relief
10. Source Precision Medicine, Inc. d/b/a Source MDx Announces Foundational Patents Will Be Offered for Sale on April 29, 2011
11. Alzheimers Drug Discovery Foundation Supports ADispell Technology with a Grant to Advance Novel Drug Candidates for Alzheimers Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/12/2017)... FRANCISCO , Sept. 12, 2017  ValGenesis ... Management Solutions (VLMS), is pleased to announce the ... a member of its Board of Directors and ... ValGenesis VLMS enables life science companies to manage ... the use of paper in this process. Furthermore, ...
(Date:9/7/2017)... two decades, New Life Agency has been committed to providing the best ... Agency announces a powerful three-way partnership designed to deliver substantial savings on ... ... http://www.schrafts2.com/ (PRNewsfoto/PharmaCareCard) ... http://pharmacarecard.com/ (PRNewsfoto/PharmaCareCard) ...
(Date:9/6/2017)... Sept. 6, 2017  Robert G. Szewc, M.D., is ... Member in recognition of his contributions to the Medical ... a Nephrologist at the practice of Kidney and Hypertension ... care and hypertension solutions. He has worked in this ... career experience, as well as expertise in kidneys, hypertension, ...
Breaking Medicine Technology:
(Date:9/20/2017)... ... September 20, 2017 , ... Five consumer packaged goods (CPG) products ... in 27 different categories. Nopavera Plus was named to the short list ... at SupplySide West 2017 during presentations at SupplySide Central on Sept. 27 and 28 ...
(Date:9/20/2017)... ... September 20, 2017 , ... Medicare doesn’t have the authority ... gouging for their prescription drugs, according to a new comparison of drug plans ... our behalf, there’s no consistency in drug pricing among drug plans,” states TSCL’s ...
(Date:9/20/2017)... ... September 20, 2017 , ... Recognising that in ... from Leany Greeny delivers positive results in just three weeks. Setting the groundwork ... the metabolism. Fitting seamlessly into hectic work and family schedules, participants can lose ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... addiction. “RECYCLED Ezekiel's Plan for Freedom from ADDICTION” is the creation of ... in the field of addiction and homeless services, including more than a decade ...
(Date:9/20/2017)... , ... September 20, 2017 , ... Houston, Texas, investment ... took Friday, September 8, and Monday, September 11, off work and rolled up their ... Church before heading to local homes to start the process of rebuilding. , CORDA ...
Breaking Medicine News(10 mins):